The downward adjustment in price targets by analysts, combined with reported revenue challenges, suggests potential short-term pressure on DuPont's stock price. However, the company's strong market position in specialty chemicals and its portfolio of patented products like Kevlar, Tyvek, and Nomex could mitigate some of the negative impacts. The mixed analyst ratings, with both downgrades and upgrades, reflect uncertainty and changing market dynamics that investors should monitor closely.